Moreover, the application of TATA-box-targeting siRNAs to specifically activate some important genes, such as insulin, tumor repressor genes (p21) or DNA repair genes (BRCA2), may provide a new safe treatment strategy for many diseases such as cancer and diabetes. Here, BRCA2 is linked to diabetes mellitus.